SCHEMBL17075145

SCHEMBL17075145

O=C1CC(C2CC2(F)F)c2ccccc2N1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.50
BRD4 O60885 7/20 0.42
CREBBP Q92793 7/20 0.42
EP300 Q09472 1/20 0.42
TSHR P16473 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TP53 P04637 1/20 0.38
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.38
LMNA P02545 2/20 0.38
AHR P35869 1/20 0.37
PDK2 Q15119 1/20 0.37
NPC1 O15118 1/20 0.36
MAPK13 O15264 1/20 0.36
MAPK12 P53778 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17075121 0.74 ALDH1A1 (0.54) ALDH1A1BRD4CREBBPEP300TSHR
SCHEMBL17075112 0.72 KDM1A (0.35)
SCHEMBL17075148 0.72 ALDH1A1 (0.48) ALDH1A1BRD4CREBBPEP300TSHR
SCHEMBL25111957 0.70 ALDH1A1 (0.57) ALDH1A1BRD4CREBBPEP300TSHR
SCHEMBL30528072 0.70 ALDH1A1 (0.57) ALDH1A1BRD4CREBBPEP300TSHR
SCHEMBL8693351 0.70 ALDH1A1 (0.62) ALDH1A1BRD4CREBBPEP300TSHR
SCHEMBL434921 0.70 CREBBP (0.58) ALDH1A1BRD4CREBBPEP300TSHR
SCHEMBL9366324 0.70 CREBBP (0.58) ALDH1A1BRD4CREBBPEP300TSHR
SCHEMBL12050556 0.70 ALDH1A1 (0.57) ALDH1A1BRD4CREBBPEP300TSHR
SCHEMBL6219390 0.70 CREBBP (0.58) ALDH1A1BRD4CREBBPEP300TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3116873-B1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL ABBVIE DEUTSCHLAND (DE) 2018-02-28 EP disclosed
US-20170158693-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL ABBVIE DEUTSCHLAND (DE) 2017-06-08 US disclosed
US-9573950-B2 Substituted [1,4]diazepino[6,7,1-ij]quinolines as serotonin 5-HT2C receptor modulators ABBVIE DEUTSCHLAND GMBH & CO KG (DE) 2017-02-21 US disclosed
EP-3116873-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2017-01-18 EP disclosed
US-20150259343-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2015-09-17 US disclosed
WO-2015136090-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL AbbVie Deutschland GmbH & Co. KG (DE) 2015-09-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170158693-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL HTR2C, HTR2A, HTR5A ALDH1A1 949/4885BRD4 1775/4885CREBBP 2507/4885
US-20150259343-A1 HEXAHYDRODIAZEPINOQUINOLINES CARRYING A CYCLIC RADICAL HTR2C, HTR2A, HTR5A ALDH1A1 949/4885BRD4 1775/4885CREBBP 2507/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.